TET2 and chronic myelomonocytic leukemia: SRSF2 mutation was reported with a high frequency of 28–47% [41–43, 53] in other cohorts of CMML patients and was reported to be significantly associated with higher age, higher hemoglobin, normal karyotype and TET2 mutation [26, 45, 54].